-
CTN Northeast Node Science Series: Injecting Hope: Repurposing GLP-1 Receptor Agonists for Treating SUDs (May 21, 2026, 12-1pm ET)
Join the CTN Northeast Node for the next installment of their virtual Science Series, featuring presenter Joji Suzuki, MD, FACLP, PI of the SuzukiLab at Brigham and Women’s Hospital, speaking about the use of GLP-1 receptor agonists for treatment substance use disorders (SUDs). This 1-hour session on May 21, 2026 (12-1pm ET) will cover the basic pharmacology of GLP-1 receptor agonists and related medications. Then the emerging evidence-base for their use in treating substance use disorders in humans will be reviewed. Finally, the talk will cover the various issues and concerns that are now being raised when using GLP-1 receptor agonists. Register for the session here! Posted on April 20, 2026
-
CTN T&I SIG Survey of Implementation Research Interests and Training Needs
Members of the CTN Translation & Implementation Special Interest Group (T&I SIG) from the Center for Dissemination & Implementation At Stanford (C-DIAS) invite you to complete a brief, online survey to understand implementation research interests and training needs in the field of addiction research. The survey is confidential and will take about 5 minutes to complete. After completing the survey, you will have an opportunity to enter your email address on a separate form to receive an aggregate summary of survey findings. If you would like to participate, please access the survey here. The survey will be open through Monday, May 4, 2026. If you have any questions, please contact Dr. Mark McGovern, Professor of Psychiatry and of Medicine at Stanford University School of Medicine, at mpmcg@stanford.edu. Thank you for helping shape future implementation research training and capacity-building efforts for the field of addiction research! Posted on April 20, 2026
-
NIDA GCP Training Update
-
CTN Community Representation Council Meeting Summary (February 2026)
The CTN Community Representative Council (CIRCL) is a collaborative of the national CTN that comes together bimonthly to courageously share what’s happening in their communities. This brief is an overview of topics discussed at this meeting and is not an exhaustive review. Download a copy of the brief. The following themes and discussions were highlighted during this meeting: The thoughts and experiences herein are those of CIRCL members and do not represent the National Institute on Drug Abuse or the Clinical Trials Network. The voices empowered by CIRCL are intended to drive research and clinical efforts in the CTN and across the US. Trends in substance use Public health impacts across the US Trust has been lost – how do we regain it? Hep C infection rates may be increasing Housing crisis is getting worse for people with substance use Despite challenges, solutions rise to the top Posted on April 13, 2026.
-
News from the New York Node: Dr. Peggy Swarbrick Receives NJAMHAA Trailblazer in Wellness Award!
On behalf of the CTN New York Node and our academic partners, including Dr. Denise Hien at Rutgers University, big congratulations to Dr. Margaret (Peggy) Swarbrick on her New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA) Trailblazer in Wellness Award! Dr. Swarbrick is the Associate Director of the Rutgers Center of Alcohol & Substance Use Studies and a Research Professor at the Graduate School of Applied and Professional Psychology. The Center of Alcohol & Substance Use Studies and the larger Graduate School of Applied and Professional Psychology community celebrate Dr. Peggy Swarbrick, deserving recipient of the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA) Trailblazer in Wellness Award! This honor is part of the organization’s Diamond Courage & Compassion Awards, recognizing leaders who have made outstanding contributions to behavioral health systems over their remarkable three-quarters of a century history. Dr. Swarbrick will be recognized in April at the NJAMHAA75 Spring Conference. We applaud her unwavering dedication, indelible impact, and continuous efforts to advance wellness and recovery-focused care! Read more about Dr. Swarbrick and her award here! Posted on April 10, 2026.
-
New in the Library (March – April 2026)
Here are the latest items added to the CTN Dissemination Library for March – April 2026 (this post will be updated as new items come in): Health plan disenrollment and mortality after initiation of medications for opioid use disorder. Nguyen AP, et al. JAMA Psychiatry 2026 (in press). Comparative effectiveness of social-contextual treatments for improving substance-related problems among Black adults: An individual-level data synthesis. Espinosa A, et al. Addiction 2026 (in press). (CTN-0125) Patient characteristics associated with successful initiation of extended-release naltrexone in the X:BOT trial. Potter K, et al. Substance Use & Misuse 2026 (in press). (CTN-0051) Research ethics in stopping opioid use disorder medication [editorial]. Weiss RD, et al. JAMA Psychiatry 2026 (in press). (CTN-0100) Posted on April 1, 2026; updated April 10, 2026
-
University of Cincinnati (Ohio Valley Node) Summer Speaker Series is Back!
Join host Ohio Valley Node PI T. John Winhusen, PhD, this summer for the University of Cincinnati/UC Health Addiction Center’s webinar series! This series will highlight cutting-edge UC addiction research and UC-community collaborations focused on prevention and treatment. Schedule June 10, 2026 | 12-1pm ETBeyond Daily Dosing: Comparing Extended-Release and Sublingual Buprenorphine for Opioid Use Disorder in Pregnancy and Postpartum – Research Evidence and Lived ExperienceT. John Winhusen, PhD (U. Cincinnati) and Kelsie Buchanan (Recovery Advocate) July 8, 2026 | 12-1pm ETCharacterizing Heavy Drinking in Midlife and Older Adults via Mixed MethodsVictor Schneider, PhD (U. Cincinnati) and Christian C. Garcia, PhD (U. Cincinnati) August 12, 2026 | 12-1pm ETTowards Personalized Medicine for Opioid Use Disorder: Analyses of Data from the Veterans Health AdministrationCorey J. Hayes, PharmD, PhD, MPH (U. Arkansas) and Daniel Bebo, MD (U. Cincinnati) Register for the series here! Posted on April 8, 2026
-
Now in the CTN Library: NIDA CTN Common Data Elements
The NIDA CTN Common Data Elements website has moved to the CTN Dissemination Library! The CTN-CDE portal provides a single source for National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN)-recommended Common Data Elements (CDEs) of Substance Use Disorders for use in clinical trials and electronic health records (EHRs). A “data element” describes the (data base) characteristics for a discrete piece of data that will be collected, stored or exchanged during the course of a study or a health examination, but does not include the collected data. A “common data element” is one that can be applied to multiple data sets across different studies or institutions, helping to improve data quality and promote data sharing. Check out the new CDE resource here!
